Generalized strong curvature singularities and weak cosmic censorship in cosmological space-times

Autor: Rudnicki, W., Budzynski, R. J., Kondracki, W.

Publikováno v: Mod.Phys.Lett. A21 (2006) 1501-1510

This paper is a further development of the approach to weak cosmic censorship proposed by the authors in Ref. 5. We state and prove a modified version of that work's main result under significantly relaxed assumptions on the asymptotic structure of s

Externí odkaz: http://arxiv.org/abs/gr-qc/0606007

On the strength of the Kerr singularity and cosmic censorship

Autor: Rudnicki, W., Zieba, P.

Publikováno v: Phys.Lett. A268 (2000) 228-234

It has been suggested by Israel that the Kerr singularity cannot be strong in the sense of Tipler, for it tends to cause repulsive effects. We show here that, contrary to that suggestion, nearly all null geodesics reaching this singularity do in fact

Externí odkaz: http://arxiv.org/abs/gr-qc/0003068

Testing Cosmic Censorship in Kerr-like Collapse Situations

Autor: Rudnicki, W.

Publikováno v: Mod.Phys.Lett. A12 (1997) 2237-2242

According to the cosmic censorship hypothesis of Penrose, naked singularities should never occur in realistic collapse situations. One of the major open problems in this context is the existence of a naked singularity in the Kerr solution with |a|>m;

Externí odkaz: http://arxiv.org/abs/gr-qc/9710022

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach

Autor: Kueffner R., Zach N., Bronfeld M., Norel R., Atassi N., Balagurusamy V., Di Camillo B., Chio A., Cudkowicz M., Dillenberger D., Garcia-Garcia J., Hardiman O., Hoff B., Knight J., Leitner M. L., Li G., Mangravite L., Norman T., Wang L., Xiao J., Fang W. -C., Peng J., Yang C., Chang H. -J., Stolovitzky G., Alkallas R., Anghel C., Avril J., Bacardit J., Balser B., Balser J., Bar-Sinai Y., Ben-David N., Ben-Zion E., Bliss R., Cai J., Chernyshev A., Chiang J. -H., Chicco D., Corriveau B. A. N., Dai J., Deshpande Y., Desplats E., Durgin J. S., Espiritu S. M. G., Fan F., Fevrier P., Fridley B. L., Godzik A., Golinska A., Gordon J., Graw S., Guo Y., Herpelinck T., Hopkins J., Huang B., Jacobsen J., Jahandideh S., Jeon J., Ji W., Jung K., Karanevich A., Koestler D. C., Kozak M., Kurz C., Lalansingh C., Larrieu T., Lazzarini N., Lerner B., Lesinski W., Liang X., Lin X., Lowe J., Mackey L., Meier R., Min W., Mnich K., Nahmias V., Noel-Macdonnell J., O'donnell A., Paadre S., Park J., Polewko-Klim A., Raghavan R., Rudnicki W., Saghapour E., Salomond J. -B., Sankaran K., Sendorek D., Sharan V., Shiah Y. -J., Sirois J. -K., Sumanaweera D. N., Usset J., Vang Y. S., Vens C., Wadden D., Wang D., Wong W. C., Xie X., Xu Z., Yang H. -T., Yu X., Zhang H., Zhang L., Zhang S., Zhu S.

Publikováno v: Scientific Reports
Scientific reports, vol 9, iss 1
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease where substantial heterogeneity in clinical presentation urgently requires a better stratification of patients for the development of drug trials and clinical care. In this stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749018b7eb39036df10edded4e83307f
http://europepmc.org/articles/PMC6345935

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.